Heart Failure Clinics

Papers
(The TQCC of Heart Failure Clinics is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Unusual Forms of Pulmonary Hypertension30
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure23
Tafamidis in the Treatment of ATTR-related Cardiomyopathy22
Fabry Disease18
Genetic Risk Stratification in Arrhythmogenic Left Ventricular Cardiomyopathy18
Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias17
When all Else Fails, Try This15
Forthcoming Issues14
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging14
Changing Landscape of Heart Failure Imaging14
Preload Reduction Therapies in Heart Failure13
Contributors12
Contributors12
Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications12
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now12
Genetics of High-Altitude Pulmonary Edema11
Arrhythmias in Adult Congenital Heart Disease Heart Failure11
Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure11
Mitral Regurgitation11
Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction11
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure10
Contributors10
Copyright9
Emerging Roles for Artificial Intelligence in Heart Failure Imaging9
Heart Failure Clinics9
Coronary Angiography in the Evaluation of Systolic Heart Failure8
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure8
What Is New in Risk Assessment in Nuclear Cardiology?8
Hypertrophic Cardiomyopathy7
Specific Therapy in Transthyretin Amyloid Cardiomyopathy7
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis7
Arrythmia-Mediated Valvular Heart Disease7
Contributors7
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy6
Shifting the Epigenetic and Multi-Omic Frontier to Get the Heart in Top Gear6
Obtaining a Coronary Artery Calcium Score with Myocardial Perfusion Imaging6
Guide to Temporary Mechanical Support in Cardiogenic Shock6
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging6
Contributors6
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis6
Cardiac Contractility Modulation6
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease5
Epigenetics of Heart Failure5
Copyright5
SGLT2 Inhibitors in Heart Failure5
Evolving Strategies in Cardiac Amyloidosis5
Contributors5
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population5
Noncoding RNAs in Pulmonary Arterial Hypertension5
Preface5
Contents4
Copyright4
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes4
Contents4
Adults with Congenital Heart Disease and Transplant4
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification4
SGLT2 Inhibitors in Type 2 Diabetes Mellitus4
Contents4
Contents4
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study4
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors4
Aortic Valvular Stenosis and Heart Failure3
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure3
SGLT2 Inhibitors and Peripheral Vascular Events3
Forthcoming Issues3
Contents3
Exercise Testing in Pulmonary Hypertension and Heart Failure3
Risk Factors for Progression in Hypertrophic Cardiomyopathy3
Remote Monitoring Devices and Heart Failure3
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy3
The Role of Medical Therapy in Hypertrophic Cardiomyopathy3
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease3
Novel Non-pharmacological Approaches to Heart Failure3
Copyright2
Forthcoming Issues2
Pulmonary Vascular Disease Across the Continuum: From Mechanisms to Precision Care2
Advances in the Therapy of Light Chain Cardiac Amyloidosis2
Novel Approaches to Sleep Apnea in Heart Failure2
Contents2
Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?2
Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure2
Forthcoming Issues2
Copyright2
Long-term Complications of Venous Thromboembolism2
Multiomics Insights into Epigenetic Mechanisms and Their Role as Biomarkers for Acute Coronary Syndrome2
Contributors2
Adult Congenital Heart Disease2
Multimodality Imaging in the Evaluation of Hypertrophic Cardiomyopathy2
Forthcoming Issues2
Genetics of Thoracic and Thoracoabdominal Aortic Dissections and Aneurysms2
Pathophysiology of Cardiac Amyloidosis2
Clinical Use of Biomarkers in Cardiac Amyloidosis2
Latest Updates in Heart Failure Imaging2
Coronary Microvascular Dysfunction2
Changing Landscape of Heart Failure Imaging2
Imaging in Hypertrophic Cardiomyopathy: Beyond Risk Stratification2
Epigenetic Regulation in Dilated Cardiomyopathy2
Clinical Value of Positron Emission Tomography Myocardial Perfusion Imaging and Blood Flow Quantification2
0.087360858917236